相关实验视频
Updated: Feb 18, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.6K
一种新抗原适应模型预测瘤对检查点阻断免疫疗法的反应
Marta Łuksza1, Nadeem Riaz2,3, Vladimir Makarov3,4
1The Simons Center for Systems Biology, Institute for Advanced Study, Princeton, New Jersey, USA.
Nature
|November 14, 2017
概括
一个新的瘤健康模型通过分析T细胞识别的新抗原来预测免疫治疗反应. 这种模型有助于开发新的癌症免疫疗法, 并揭示了瘤和病原体进化之间的相似之处.
科学领域:
- 免疫学
- 计算生物学
- 癌症学
背景情况:
- 检查点阻断免疫疗法利用宿主免疫系统消除瘤细胞.
- 这些疗法的临床疗效与T细胞对瘤特异性新抗原的识别相关.
- 了解新抗原相互作用是预测和改善免疫治疗结果的关键.
研究的目的:
- 开发一种新的瘤适应模型来预测癌症免疫治疗的反应.
- 确定影响新抗原适应性和T细胞识别的关键因素.
- 探索瘤和病原体之间的进化相似之处.
主要方法:
- 开发了整合主要组织相容性复合体 (MHC) 结合亲和力和序列相似性的计算模型,以评估新抗原适应性.
- 根据瘤子克隆中主导新抗原的权重效应评估瘤适应性.
- 使用黑色素瘤和肺癌免疫治疗试验的患者数据验证了该模型的预测能力.
主要成果:
- 在接受抗CTLA-4和抗PD-1治疗的队列中,开发的免疫健康模型准确地预测了患者的存活率.
- 确定了特定的新抗原特征,以确定它们的适应性和对免疫治疗反应的影响.
- 证明瘤进化与快速进化的病原体的进化动态有相似之处.
结论:
- 新抗原适应性模型为预测免疫疗法的有效性提供了强大的工具.
- 低适应性新抗原是新型免疫疗法开发的潜在目标.
- 这项研究加深了我们对瘤与免疫相互作用以及癌症进化原理的理解.
相关概念视频
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
T Cell Activation and Clonal Selection
16.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.4K
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K

